000			01598 a2200493 4500
005			20250513162451.0
264		0	_c19990216
008			199902s 0 0 fre d
022			_a0007-4551
040			_aNLM _beng _cNLM
100	1		_aVan Cutsem, E
245	0	0	_a[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials]. _h[electronic resource]
260			_bBulletin du cancer _cDec 1998
300			_a33-7 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntimetabolites, Antineoplastic _xtherapeutic use
650	0	4	_aAntineoplastic Agents, Phytogenic _xadverse effects
650	0	4	_aCamptothecin _xadverse effects
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aDisease-Free Survival
650	0	4	_aDrug Resistance, Neoplasm
650	0	4	_aEnzyme Inhibitors _xadverse effects
650	0	4	_aEurope
650	0	4	_aFemale
650	0	4	_aFluorouracil _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aIrinotecan
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Proteins _xantagonists & inhibitors
650	0	4	_aPalliative Care
650	0	4	_aRemission Induction
650	0	4	_aSalvage Therapy
650	0	4	_aTopoisomerase I Inhibitors
650	0	4	_aTreatment Outcome
650	0	4	_aUnited States
700	1		_aPeeters, M
773	0		_tBulletin du cancer _gvol. Spec No _gp. 33-7
999			_c9893695 _d9893695